At a glance
In Module 8, you will learn valuable strategies to effectively and clearly communicate your analysis, findings, and recommendations from the public health assessment (PHA) process to both the public and stakeholders.
Training overview

Training objectives
At the conclusion of the session, the participant will be able to:
- Identify two reasons why writing in clear language is important.
- Identify an environmental health message written in clear language.
- Recognize three clear writing techniques that can be used to create clear and effective writing.
- Identify two available resources that can be utilized to aid public health writers in writing clear and effective communication.
Target audience
Public health professionals involved or interested in the PHA process, including:
- Environmental Health Specialists, Toxicologists, and Epidemiologists
- Community Involvement Specialists, Health Communicators, and Health Educators
- Medical Officers and Registered Nurses
- Program Managers
Continuing education units
Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WB4993 Module 8: Clear Writing of Environmental Health Information please visit CDC TRAIN and search for the course in the Course Catalog using WB4993. Follow the steps below by 05/15/2029.
- Register for and complete the course.
- Pass the post-assessment at 70%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
FEES: No fees are charged for CDC's CE activities.
Prerequisites
There are no prerequisites to complete Module 8.
Faculty/Credentials
- Traci Augustosky PhD (ABD) MAIS MS, Lead Tech Writer-Editor, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry
- Sandra M. López-Carreras BS MS, Retired from Agency for Toxic Substances and Disease Registry
- Liz Bertelsen MPH, Senior Scientist, Eastern Research Group, Inc.
- Danielle Langmann BS MS, Retired from Agency for Toxic Substances and Disease Registry
- Karen Scruton BS MS, Environmental Health Scientist, Agency for Toxic Substances and Disease Registry
- David Mellard, Ph.D., Associate Director for Science, Agency for Toxic Substances and Disease Registry
Content Experts
This course was developed by ATSDR, Office of Capacity Development and Applied Prevention Science, in collaboration with:
ATSDR's Office of Community Health and Hazard Assessment
Eastern Research Group, Inc.
National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Office of Communications
CDC Create-IT Services
Accreditation Statements
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.5. Continuing Competency credits available are 1.5. CDC provider number 98614.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a preapproved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
Disclosure
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
All the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
The Centers for Disease Control and Prevention (CDC) complies with applicable Federal civil rights laws and does not discriminate based on race, color, national origin, age, disability, religion, or sex. To learn more visit: https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html.